Royce & Associates’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-155,803
| Closed | -$3.62M | – | 834 |
|
|
2024
Q3 | $3.62M | Buy |
155,803
+24,085
| +18% | +$559K | 0.03% | 533 |
|
|
2024
Q2 | $3.21M | Hold |
131,718
| – | – | 0.03% | 554 |
|
|
2024
Q1 | $4.45M | Buy |
131,718
+1,882
| +1% | +$63.6K | 0.04% | 520 |
|
|
2023
Q4 | $4.09M | Hold |
129,836
| – | – | 0.04% | 529 |
|
|
2023
Q3 | $3.32M | Hold |
129,836
| – | – | 0.03% | 566 |
|
|
2023
Q2 | $3.72M | Buy |
129,836
+50,000
| +63% | +$1.43M | 0.04% | 565 |
|
|
2023
Q1 | $1.91M | Hold |
79,836
| – | – | 0.02% | 663 |
|
|
2022
Q4 | $1.35M | Hold |
79,836
| – | – | 0.01% | 708 |
|
|
2022
Q3 | $1.18M | Hold |
79,836
| – | – | 0.01% | 704 |
|
|
2022
Q2 | $1.26M | Hold |
79,836
| – | – | 0.01% | 720 |
|
|
2022
Q1 | $2.15M | Hold |
79,836
| – | – | 0.02% | 702 |
|
|
2021
Q4 | $2.96M | Hold |
79,836
| – | – | 0.02% | 657 |
|
|
2021
Q3 | $3.82M | Hold |
79,836
| – | – | 0.03% | 633 |
|
|
2021
Q2 | $2.7M | Hold |
79,836
| – | – | 0.02% | 722 |
|
|
2021
Q1 | $3.3M | Hold |
79,836
| – | – | 0.02% | 675 |
|
|
2020
Q4 | $3.46M | Hold |
79,836
| – | – | 0.03% | 625 |
|
|
2020
Q3 | $3.43M | Hold |
79,836
| – | – | 0.04% | 558 |
|
|
2020
Q2 | $3.73M | Sell |
79,836
-26,600
| -25% | -$1.24M | 0.04% | 518 |
|
|
2020
Q1 | $1.45M | Hold |
106,436
| – | – | 0.02% | 671 |
|
|
2019
Q4 | $1.16M | Hold |
106,436
| – | – | 0.01% | 789 |
|
|
2019
Q3 | $1.09M | Hold |
106,436
| – | – | 0.01% | 798 |
|
|
2019
Q2 | $1.01M | Hold |
106,436
| – | – | 0.01% | 833 |
|
|
2019
Q1 | $727K | Hold |
106,436
| – | – | 0.01% | 888 |
|
|
2018
Q4 | $482K | Hold |
106,436
| – | – | ﹤0.01% | 936 |
|
|
2018
Q3 | $941K | Hold |
106,436
| – | – | 0.01% | 927 |
|
|
2018
Q2 | $903K | Hold |
106,436
| – | – | 0.01% | 963 |
|
|
2018
Q1 | $585K | Hold |
106,436
| – | – | ﹤0.01% | 1036 |
|
|
2017
Q4 | $847K | Hold |
106,436
| – | – | 0.01% | 995 |
|
|
2017
Q3 | $753K | Hold |
106,436
| – | – | 0.01% | 999 |
|
|
2017
Q2 | $834K | Hold |
106,436
| – | – | 0.01% | 998 |
|
|
2017
Q1 | $849K | Buy |
106,436
+14,285
| +16% | +$114K | 0.01% | 1001 |
|
|
2016
Q4 | $1.36M | Buy |
92,151
+72,429
| +367% | +$1.07M | 0.01% | 892 |
|
|
2016
Q3 | $341K | Buy |
+19,722
| New | +$341K | ﹤0.01% | 1022 |
|